Product
IMU-935
1 clinical trial
1 indication
Clinical trial
Dose Escalation Study to Evaluate the Safety, Tolerability, and Anti-Tumor Activity of Single Agent IMU-935 in Patients With Progressive, Metastatic Castration Resistant Prostate CancerStatus: Terminated, Estimated PCD: 2023-05-31